Arcutis Biotherapeutics, Inc. (ARQT) Financials

ARQT Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 341.4 million 252.7 million
2023-09-30 293.0 million 246.2 million
2023-06-30 320.7 million 240.2 million
2023-03-31 379.5 million 239.7 million

ARQT Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 -56.3 million 8.8 million
2023-09-30 -44.0 million 10.0 million
2023-06-30 -66.8 million 10.6 million
2023-03-31 -80.4 million 9.5 million

ARQT Net Income

No data available :(

ARQT Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 272.8 million - 4.1 million
2023-09-30 227.1 million - 4.3 million
2023-06-30 268.7 million 199.8 million 4.5 million
2023-03-31 332.4 million 198.8 million 4.6 million

ARQT Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 92.6 million
2023-09-30 61.7 million
2023-06-30 61.4 million
2023-03-31 61.2 million

ARQT Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 6000 23.8 million 48.7 million -
2023-09-30 64000 26.2 million 47.6 million -
2023-06-30 276000 25.2 million 46.0 million -
2023-03-31 82000 35.3 million 5.8 million 37.1 million

ARQT Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 13.5 million 2.4 million
2023-09-30 38.1 million 1.2 million
2023-06-30 5.2 million 776000
2023-03-31 2.8 million 783000

ARQT

Price: $8.47

52 week price:
1.76
15.40

Earnings Per Share: -3.78 USD

P/E Ratio: -1.40

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Volume: 827862

Market Capitalization: 1.3 billion

Links: